How clinics evaluate a stem cell supplier (and what the label really means)

What clinics actually find when they search for a stem cell supplier

Clinics searching for a stem cell supplier should distinguish search terminology from documented cell content.

A Wharton's jelly allograft is processed umbilical cord tissue, supplied as a scaffold product, not a cultured cell line and not a stem cell therapy. Confirming that distinction before comparing vendors keeps the evaluation focused on documentation rather than on a search label.

What the published evidence says about cell content in commercial cord allografts

The International Society for Cell and Gene Therapy defines mesenchymal stromal cells by minimal criteria: plastic adherence, expression of surface markers including CD73, CD90, and CD105, and tri-lineage differentiation capacity in culture. Those criteria exist because "stem cell" is otherwise an imprecise marketing term, not a laboratory standard.

An independent analysis of six commercial umbilical cord allografts reported low total cell counts and low cell viability, with only rare viable mesenchymal stromal cells identified. A separate study of five commercial cord tissue products found no colony-forming mesenchymal stromal cells in any of them.

Taken together, this evidence does not support labeling a commercial cord tissue allograft a stem cell product. It does not establish how a specific supplier processes tissue, lot-to-lot variability, or matrix composition beyond what each study measured. Buyers who understand this gap can ask sharper questions than "does this contain stem cells," starting with what the lot documentation actually characterizes.

Documents to request before opening an account

A credentialed supplier should be able to produce, on request, a donor eligibility summary describing medical and social history screening and communicable disease testing, a certificate of analysis for the specific lot being purchased, and a sterility testing report from a third-party laboratory.

These documents should reference a unique lot identifier that ties the physical unit a clinic receives back to its testing record. If a supplier cannot produce lot-specific documentation on request, ask why before proceeding.

• Donor eligibility summary (medical and social history, serology screening)
• Certificate of analysis tied to a unique lot identifier
• Third-party sterility testing report
• Confirmation of quarantine until release criteria are met

Where regulatory questions belong in a stem cell supplier evaluation

Human cell and tissue products are regulated under 21 CFR 1271.10. Whether a specific intended use meets all applicable criteria in that regulation, for a product to be regulated solely under section 361 of the Public Health Service Act, is a determination for the clinic and its own regulatory counsel.

This section is general information, not legal advice. Clinics evaluating any supplier claiming a particular regulatory status should ask for the basis of that claim in writing and review it with counsel before relying on it.

A short framework for comparing suppliers side by side

A simple framework for comparison: what is the product (tissue allograft, not a cultured cell line), what documentation accompanies each lot, what does that documentation actually characterize, and what is the supplier's stated regulatory position and its basis for it.

• Product identity: tissue allograft, formulated product, or lyophilized format
• Lot documentation: COA, donor eligibility, sterility testing
• Characterization claims: what was tested, by whom, using what method
• Regulatory position: stated framework and supporting basis, reviewed by counsel

What to do if a supplier can't produce documentation

If a prospective supplier cannot produce lot-specific documentation on request, or answers questions about cell content without laboratory data, treat that as useful information on its own. Confirming an NPI number before an order is processed is a basic indicator that a supplier restricts sales to licensed professionals rather than consumers.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.